FIELD: medicine, pharmaceutics.
SUBSTANCE: there are offered 5-substituted quinazolinone compounds having general structural formulas 
(II), 
(III) and 
(IV) or their pharmaceutically acceptable salts and stereomers. The radicals and symbols in the structural formulas presented below are designated as shown in the patent claim.
EFFECT: there are disclosed the methods for using and the pharmaceutical compositions of quinazolinone compounds.
16 cl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 5-SUBSTITUTED QUINAZOLINONE, COMPOSITIONS CONTAINING THEM AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2617989C2 |
| 6-, 7- OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM | 2008 |
|
RU2476432C2 |
| ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
| 4, O-SUBSTITUTED ISOINDOLINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM | 2008 |
|
RU2471794C2 |
| DERIVATIVES OF 7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-3-ENE, USEFUL FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2645678C2 |
| CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
| SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
| DERIVATIVES OF 2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE, THEIR SYNTHESIS AND APPLICATION AS INHIBITORS OF INFLAMMATORY CYTOKINES | 1999 |
|
RU2200159C2 |
| ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
